- Home
- HSCS vs LRE Comparison
HSCS vs LRE Comparison
Compare HSCS & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSCS | LRE |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 17.9M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HSCS | LRE |
|---|---|---|
| Price | $3.31 | $1.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 124.8K | 12.8K |
| Earning Date | 09-14-2026 | 07-30-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,319.00 | N/A |
| Revenue This Year | $295.93 | N/A |
| Revenue Next Year | $18,321.05 | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $1.00 |
| 52 Week High | $5.25 | $1.86 |
Technical Indicators
Market Signals| Indicator | HSCS | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 40.35 |
| Support Level | $1.84 | $1.05 |
| Resistance Level | $3.72 | $1.41 |
| Average True Range (ATR) | 0.36 | 0.04 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 6.32 | 37.50 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.